Ninio E et al. |
Biosynthesis of platelet-activating factor. I. Evidence for an acetyl-transferase activity in murine macrophages. |
1982 |
Biochim. Biophys. Acta |
pmid:7055592
|
Long MW et al. |
Immature megakaryocytes in the mouse: physical characteristics, cell cycle status, and in vitro responsiveness to thrombopoietic stimulatory factor. |
1982 |
Blood |
pmid:7059669
|
Humphrey DM et al. |
Vasoactive properties of acetyl glyceryl ether phosphorylcholine and analogues. |
1982 |
Lab. Invest. |
pmid:7070056
|
Arnoux B et al. |
Release of PAF-acether from human blood monocytes. |
1982 |
Agents Actions |
pmid:7164946
|
Fouque F et al. |
Platelet-activating factor (PAF-acether): thromboxane-independent synergism with adrenaline on human platelets and recent insights into its mode of action. |
1982 |
Agents Actions |
pmid:7164947
|
Lefort J et al. |
Pharmacological properties of PAF-acether in the guinea-pig: platelet-dependent and independent reactions. |
1982 |
Agents Actions |
pmid:7164948
|
Lanara E et al. |
Response of mice and mouse platelets to acetyl glyceryl ether phosphorylcholine. |
1982 |
Biochem. Biophys. Res. Commun. |
pmid:7168759
|
Basran GS et al. |
Cromoglycate (DSCG) inhibits responses to platelet-activating factor (PAF-acether) in man: an alternative mode of action for DSCG in asthma? |
1982 |
Eur. J. Pharmacol. |
pmid:6819153
|
Hopkins NK et al. |
Evidence for mediation of acetyl glyceryl ether phosphorylcholine stimulation of adenosine 3',5'-(cyclic)monophosphate levels in human polymorphonuclear leukocytes by leukotriene B4. |
1983 |
Biochim. Biophys. Acta |
pmid:6313071
|
Czarnetzki B |
Increased monocyte chemotaxis towards leukotriene B4 and platelet activating factor in patients with inflammatory dermatoses. |
1983 |
Clin. Exp. Immunol. |
pmid:6317241
|
Stimler NP and O'Flaherty JT |
Spasmogenic properties of platelet-activating factor: evidence for a direct mechanism in the contractile response of pulmonary tissues. |
1983 |
Am. J. Pathol. |
pmid:6624879
|
Camussi G et al. |
Biosynthesis and release of platelet-activating factor from human monocytes. |
1983 |
Int. Arch. Allergy Appl. Immunol. |
pmid:6826235
|
Morley J et al. |
Inflammatory actions of platelet activating factor (Pafacether) in guinea-pig skin. |
1983 |
Br. J. Pharmacol. |
pmid:6685552
|
Hornby EJ and Perry CR |
1-O-hexadecyl-2-acetyl-sn-3-glycerophosphorylcholine (PAF): some effects on the aggregation of human platelets by thrombin or collagen. |
1983 |
Thromb. Haemost. |
pmid:6636035
|
Patterson R and Harris KE |
The activity of aerosolized and intracutaneous synthetic platelet activating factor (AGEPC) in rhesus monkeys with IgE-mediated airway responses and normal monkeys. |
1983 |
J. Lab. Clin. Med. |
pmid:6644157
|
Ogihara T et al. |
[Renomedullary hypotensive lipids and prostaglandins]. |
1983 |
Horumon To Rinsho |
pmid:6368051
|
Valone FH and Goetzl EJ |
Specific binding by human polymorphonuclear leucocytes of the immunological mediator 1-O-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphorylcholine. |
1983 |
Immunology |
pmid:6848449
|
Chilton FH et al. |
Metabolic fate of platelet-activating factor in neutrophils. |
1983 |
J. Biol. Chem. |
pmid:6853486
|
Stormorken H et al. |
A new bleeding disorder: lack of platelet aggregatory response to adrenaline and lack of secondary aggregation to ADP and platelet activating factor (PAF). |
1983 |
Thromb. Res. |
pmid:6857589
|
Hubbard JW et al. |
Antihypertensive effects of I-hexadecyl-2-acetyl-sn-glycero-3-phosphocholine on plasma renin activity and catecholamine responses in spontaneously hypertensive rats. |
1983 |
Life Sci. |
pmid:6337313
|